BPC157 & TB500 32 Pen
Pre-filled research pen containing 16mg BPC-157 and 16mg TB-500 (Thymosin Beta-4 Acetate). For research purposes only.
BodyPharm UAE supplies BPC157 & TB500 32 Pen for research purposes across Dubai, Abu Dhabi, Sharjah, and the wider UAE. All compounds are sourced to strict purity standards and shipped with secure, trackable delivery.
Research Areas
Designed for advanced research in these areas
Musculoskeletal tissue repair mechanisms
Inflammatory pathway modulation
Gastrointestinal cytoprotection studies
Post-injury tissue remodelling research
Certificate of Analysis
Verified by independent & in-house laboratory testing
Janoshik Analytical
Third-party laboratory
Report
#106569
Batch
BCTB0178
Purity
99.13% / 99.36%
Sample
32mg pen 3ml
In-House Testing
Body Pharm laboratory
Report
#250710
Batch
BCTB0178
Purity
TB: 99.13% BPC: 99.36%
Concentration
5.4 mg/ml
Precision Engineered
This dual-peptide formulation combines BPC-157, a pentadecapeptide originally isolated from gastric juice and studied for its role in tissue-protective signalling, with TB-500 (Thymosin Beta-4 fragment), a synthetic peptide investigated for its involvement in cell migration, angiogenesis, and wound-repair pathways. The combination is of particular interest in research exploring synergistic tissue-repair mechanisms.
Research Background
BPC-157 (Body Protection Compound-157, CAS 137525-51-0, ~1419 g/mol) is a synthetic pentadecapeptide studied in vitro and in preclinical models for interactions with nitric oxide signalling, VEGF and EGF growth-factor pathways, and cytoprotection. TB-500 is a synthetic form of the actin-sequestering peptide Thymosin Beta-4, studied for actin dynamics, cell migration, and angiogenesis.
The two are examined together because their proposed mechanisms, growth-factor modulation and cytoskeletal regulation, are distinct but may overlap in tissue-remodelling assays. These observations come from cell and animal models and are not established in humans. Supplied for in vitro and laboratory research only.
Frequently Asked Questions
A dual-peptide formulation of BPC-157 (a gastric-juice-derived pentadecapeptide) and TB-500 (synthetic Thymosin Beta-4), both studied in preclinical tissue-repair, angiogenesis, and matrix-remodelling research. For laboratory research only.
BodyPharm sells BPC-157 + TB-500 strictly for research purposes. Customers are responsible for understanding applicable regulations in their jurisdiction.
BPC-157 is studied for nitric oxide signalling, growth-factor pathways, and wound-healing transcription factors; TB-500 for actin dynamics and cell migration. Findings are from cell and animal models, not human trials.
Their proposed mechanisms, growth-factor modulation and cytoskeletal regulation, are distinct but may overlap in tissue-remodelling models.
Refrigerated at 2 to 8 degrees Celsius, away from heat and light.
One pre-filled research pen with 16mg BPC-157 and 16mg TB-500 (32mg total), and a batch Certificate of Analysis on request.
What Researchers Say
How was our customer service? Did your delivery arrive on time? Was the product what you expected? Let us know and receive 10% off and free delivery with your next order.
Specifications
Premium-grade formulation for advanced research
32mg
Total Content
≥99%
Purity
Pre-filled Research Pen
Format
2-8°C Refrigerated
Storage
0.25mg, 0.5mg, 0.75mg, 1mg
Volume Options
BPC-157 & TB-500
Active Ingredient
Body Protection Compound-157 (pentadecapeptide, GEPPPGKPADDAGLV)
BPC-157 Compound Name
137525-51-0
BPC-157 CAS
~1419 g/mol (C62H98N16O22)
BPC-157 MW
Synthetic Thymosin Beta-4 (TB-500)
TB-500 Compound Name
885340-08-9
TB-500 CAS
~4963 g/mol (full Thymosin Beta-4; ~889 g/mol for Ac-LKKTETQ fragment)
TB-500 MW
HPLC (Janoshik)
Verification
Ready to order?
BPC157 & TB500 32 Pen
AED 850
Same day delivery across the UAE